Nagi Bioscience

Lausanne, Switzerland

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

$13.6M raised

Sep 2023

Series A

Biotechnology

Top Investors

Verve Venturesimec.xpandEuropean Innovation CouncilMassChallengeZúrcher Kantonal Bank

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nagi Bioscience

How much funding has Nagi Bioscience raised?

Nagi Bioscience has raised $13.6M in total funding. The most recent round was Series A. The last funding was announced in September 2023.

Who are Nagi Bioscience's investors?

Nagi Bioscience's investors include Verve Ventures, imec.xpand, European Innovation Council, MassChallenge, Zúrcher Kantonal Bank.

Where is Nagi Bioscience headquartered?

Nagi Bioscience is headquartered in Lausanne, Switzerland.

What does Nagi Bioscience do?

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

What stage is Nagi Bioscience at?

Nagi Bioscience is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 28, 2023.

MLA

"Nagi Bioscience — Funding & Investors." VCBacked, September 28, 2023, https://www.vcbacked.co/company/nagi-bioscience. Accessed June 3, 2026.

APA

VCBacked. (2023). Nagi Bioscience — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/nagi-bioscience

Wikipedia (cite web)

{{cite web |title=Nagi Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/nagi-bioscience |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 28, 2023.

Similar Companies in Biotechnology